PATH2 HYDROGEN AG (PTHH.DE) Fundamental Analysis & Valuation

FRA:PTHH • DE000A1A6WB2

Current stock price

0.6 EUR
-0.05 (-7.69%)
Last:

This PTHH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PTHH.DE Profitability Analysis

1.1 Basic Checks

  • PTHH had negative earnings in the past year.
  • In the past 5 years PTHH reported 4 times negative net income.
  • In the past 5 years PTHH always reported negative operating cash flow.
PTHH.DE Yearly Net Income VS EBIT VS OCF VS FCFPTHH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -35.52%
ROE -65.57%
ROIC N/A
ROA(3y)-50.49%
ROA(5y)-71.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTHH.DE Yearly ROA, ROE, ROICPTHH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PTHH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PTHH.DE Yearly Profit, Operating, Gross MarginsPTHH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. PTHH.DE Health Analysis

2.1 Basic Checks

  • PTHH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PTHH has more shares outstanding
  • The number of shares outstanding for PTHH has been increased compared to 5 years ago.
  • PTHH has a worse debt/assets ratio than last year.
PTHH.DE Yearly Shares OutstandingPTHH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
PTHH.DE Yearly Total Debt VS Total AssetsPTHH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of 0.25, we must say that PTHH is in the distress zone and has some risk of bankruptcy.
  • PTHH has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACCN/A
WACC8.41%
PTHH.DE Yearly LT Debt VS Equity VS FCFPTHH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

2.3 Liquidity

  • A Current Ratio of 0.04 indicates that PTHH may have some problems paying its short term obligations.
  • PTHH has a Quick Ratio of 0.04. This is a bad value and indicates that PTHH is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
PTHH.DE Yearly Current Assets VS Current LiabilitesPTHH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PTHH.DE Growth Analysis

3.1 Past

  • PTHH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.58%.
  • PTHH shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.67%.
EPS 1Y (TTM)-4.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.86%
Revenue 1Y (TTM)40.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.78%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTHH.DE Yearly Revenue VS EstimatesPTHH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2024 20K 40K 60K

More info and screens

Find the best growth stocksShow best growing peers

0

4. PTHH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PTHH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTHH.DE Price Earnings VS Forward Price EarningsPTHH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTHH.DE Per share dataPTHH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PTHH.DE Dividend Analysis

5.1 Amount

  • No dividends for PTHH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PTHH.DE Fundamentals: All Metrics, Ratios and Statistics

PATH2 HYDROGEN AG

FRA:PTHH (4/1/2026, 7:00:00 PM)

0.6

-0.05 (-7.69%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)04-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.86%
Ins Owner ChangeN/A
Market Cap66.91M
Revenue(TTM)189.90K
Net Income(TTM)-8.52M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 352.35
P/FCF N/A
P/OCF N/A
P/B 5.15
P/tB 5.85
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.12
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.52%
ROE -65.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.49%
ROA(5y)-71.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 0.25
F-ScoreN/A
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-196.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-195.77%
OCF growth 3YN/A
OCF growth 5YN/A

PATH2 HYDROGEN AG / PTHH.DE Fundamental Analysis FAQ

What is the fundamental rating for PTHH stock?

ChartMill assigns a fundamental rating of 0 / 10 to PTHH.DE.


Can you provide the valuation status for PATH2 HYDROGEN AG?

ChartMill assigns a valuation rating of 0 / 10 to PATH2 HYDROGEN AG (PTHH.DE). This can be considered as Overvalued.


How profitable is PATH2 HYDROGEN AG (PTHH.DE) stock?

PATH2 HYDROGEN AG (PTHH.DE) has a profitability rating of 0 / 10.